使用Acanthamoeba spp. 的时间. 作为一个细胞模型来评估Leishmania感染
Helena Lúcia Carneiro Santos1,2,3, Gabriela Linhares Pereira1, Rhagner Bonono do Reis1
1Laboratório de Doenças Parasitárias, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Rio de Janeiro, Brazil.
PLoS neglected tropical diseases
|October 2, 2024
概括
莱什曼尼亚寄生虫感染并在非哺乳动物模型生物Acanthamoeba中复制. 这一发现提供了一个新的细胞模型来研究Leishmania宿主-寄生虫相互作用和疾病病原性.
科学领域:
- 寄生虫学的寄生虫学
- 细胞生物学 细胞生物学
- 传染性疾病 传染性疾病
背景情况:
- 莱什曼病造成了重大的全球健康挑战,原因是药物耐药性,有毒治疗和并发感染.
- 了解早期宿主-寄生虫相互作用对于疾病控制至关重要.
- 巨细胞是Leishmania的主要宿主细胞,但需要更简单的模型.
研究的目的:
- 为了评估Acanthamoeba spp. 的价值. 作为一种简单的细胞模型,用于研究莱什曼菌的传染性.
- 为了评估Acanthamoeba和巨菌在托管Leishmania寄生虫中的相似性.
主要方法:
- 与各种莱什马尼亚物种 (L. infantum,L. amazonensis,L. major,L. braziliensis) 共同培养阿坎萨摩巴卡斯塔利尼和阿坎萨摩巴多菌.
- 使用光和光显微镜观察寄生虫与宿主相互作用.
- 在Acanthamoeba中分析寄生虫的转化和复制.
主要成果:
- 莱什马尼亚的前列腺菌被阿坎塔莫巴通过伪足体内化.
- 内化寄生虫转化为像虫的形式,并生产性地复制.
- 在真空孔,法哥利索索姆和Acanthamoeba的细胞质中观察到细胞内巨.
- 阿坎塔莫巴在感染后没有表现出快速退化或溶解.
结论:
- 亚坎他莫巴菌种类. 支持Leishmania感染和复制,作为一个可行的模型.
- 这些虫可以帮助阐明Leishmania感染哺乳动物细胞的机制.
- 对这些相互作用的进一步研究可能会揭示对病原体利用策略的新见解.
更多相关视频
10:01Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites
Published on: March 16, 2018
10.5K
06:57In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
8.2K
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
